|
|
Committees
Executive Scientific Committee
Members
| Dr Michel BALTAS (CNRS, University of Toulouse, Toulouse, France) |
| Prof. Vania BERNARDES-GENISSON (University of Toulouse, Toulouse, France) |
| Prof. Dominique BONNET (CNRS-University of Strasbourg, Illkirch, France) |
| Dr Gilbert LASSALLE (Evotec, Toulouse, France) |
| Prof. Sebastien PAPOT (SCT & University of Poitiers, Poitiers, France) |
| Dr Michel PEREZ (Pierre Fabre, Toulouse, France) |
| Prof. Janos SAPI (SCT & University of Reims-Champagne-Ardenne, Reims, France) |
| Dr Luc VAN HIJFTE (SCT & Novithera, Nijmegen, The Netherlands) |
Local Organising Committee
Members
| Ms Marie-Angèle ALBOUY (University Paul Sabatier-Toulouse 3, Toulouse, France) |
| Dr Michel BALTAS (CNRS, University of Toulouse, Toulouse, France) |
| Prof. Florence BEDOS-BELVAL (University of Toulouse, Toulouse, France) |
| Prof. Vania BERNARDES-GENISSON (University of Toulouse, Toulouse, France) |
| Prof. Céline DERAEVE (University of Toulouse, Toulouse, France) |
| Mrs Fatima EL GARAH (University of Toulouse, Toulouse, France) |
| Dr Alison FRANÇOIS (University of Toulouse, Toulouse, France) |
Scientific Advisory Board
Members
| Dr Anne-Marie CAMINADE (University of Toulouse, Toulouse, France) |
| Dr Steven DURRANT (Vertex Pharmaceuticals (Europe) Ltd, Abingdon, United Kingdom) |
| Prof. Alexander DÖMLING (University of Groningen, Groningen, The Netherlands) |
| Prof. Raphaël FREDERICK (UCLouvain, Brussels-Woluwe, Belgium) |
| Dr Pascal FURET (Novartis, Basel, Switzerland) |
| Dr Pascal GEORGE (SCT & Independent Scientific Expert & Adviser, Longvilliers, France) |
| Dr Mike HANN (GSK Medicines Research Centre, Stevenage, United Kingdom) |
| Dr Lars KARLSSON (Ferring Pharmaceuticals, Copenhagen, Denmark) |
| Dr Kazuo KUBO (Kyowa Hakko Kirin Co., Ltd, Shizuoka, Japan) |
| Dr Marc LANG (Novartis Pharma, Basel, Switzerland) |
| Prof. Pierre MONSAN (INSA, Toulouse, France) |
| Prof. Christa MÜLLER (University of Bonn, Bonn, Germany) |
| Dr Masanori OKANIWA (Takeda Pharmaceutical Company, Kanagawa, Japan) |
| Dr Françoise PERRON SIERRA (Institut de Recherches Servier, Croissy sur Seine, France) |
| Prof. Edward TATE (Imperial College London, London, United Kingdom) |
| Dr Antoni TORRENS (Esteve Pharmaceuticals, Barcelona, Spain) |
| Dr Mark VAECK (Complix, Zwijnaarde, Belgium) |
| Dr Alain VICARI (Calypso Biotech, Plan-les-Ouates, Switzerland) |
| Dr Maria VICENT (Research Centre Príncipe Felipe, Valencia, Spain) |
| Dr Andrew ZHANG (AstraZeneca, Waltham, United States) |
|
Organised by
EFMC Sponsored Event
ESOF Labelised Event
Gold Sponsor
Silver Sponsor
Bronze Sponsor
|
